Fast Acting, Dry Powder, Needle-Free, Intranasal Epinephrine Spray: A Promising Future Treatment for Anaphylaxis
The Journal of Allergy and Clinical Immunology: In Practice · 2023-10 · 11 (10) · 3047-3054
DOI: 10.1016/j.jaip.2023.06.044 ↗Kurz gefasst
Klinische Studie in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2023-10. Verfasst von Yuval Tal und 12 weiteren Autor:innen. Beteiligte Einrichtung: Allergy and Clinical Immunology Unit, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. Hauptthemen laut MEDLINE: Anaphylaxis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Allergy and Clinical Immunology Unit, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
- Allergy and Clinical Immunology Unit, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel. Electronic address: oded.shamriz@mail.huji.ac.il.
- Clinical Pharmacology Unit, Hadassah Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.
- Pharma Medica Research Inc, Bioanalytical services, Mississauga, ON, Canada.
- Formulex Pharma Innovation Ltd, Pharmaceutical development and manufacturing, Nes Ziona, Israel.
- Nasus Pharma, Tel Aviv, Israel.
Zitieren
APA
Tal, Y., Ribak, Y., Rubin, L., Talmon, A., Shamriz, O., Hershko, A. Y., Blotnick, S., Bouhajib, M., Krayz, G. T., Abrutzky, C., Megiddo, D., Lapidot, T., & Caraco, Y. (2023). Fast Acting, Dry Powder, Needle-Free, Intranasal Epinephrine Spray: A Promising Future Treatment for Anaphylaxis. The Journal of Allergy and Clinical Immunology: In Practice, 11(10), 3047-3054. https://doi.org/10.1016/j.jaip.2023.06.044
Vancouver
Tal Y, Ribak Y, Rubin L, Talmon A, Shamriz O, Hershko AY, et al. Fast Acting, Dry Powder, Needle-Free, Intranasal Epinephrine Spray: A Promising Future Treatment for Anaphylaxis. The Journal of Allergy and Clinical Immunology: In Practice. 2023;11(10):3047-3054. doi:10.1016/j.jaip.2023.06.044
BibTeX
@article{Tal2023,
author = {Tal, Yuval and Ribak, Yaarit and Rubin, Limor and Talmon, Aviv and Shamriz, Oded and Hershko, Alon Y and Blotnick, Simcha and Bouhajib, Mohammed and Krayz, Galia Temtsin and Abrutzky, Carolina and Megiddo, Dalia and Lapidot, Tair and Caraco, Yoseph},
title = {Fast Acting, Dry Powder, Needle-Free, Intranasal Epinephrine Spray: A Promising Future Treatment for Anaphylaxis},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2023},
volume = {11},
number = {10},
pages = {3047--3054},
doi = {10.1016/j.jaip.2023.06.044}
}
EUVIMED